Jeffrey Borenstein
Showing 1–1 of 1 transcripts.
- Milken Institute1h 0m
New Pathways to Neuroscience Breakthroughs
Rick Berke, Cara Altimus, Jeffrey Borenstein, Niranjan Bose, Johannes Streffer, Mike Belville, David Mongeau, Janet Knupp, Jing Lu, Ian Kramer, Anna McAllister
A panel of experts highlighted the critical gap in preventing and treating brain disorders despite projections that dementia cases will double over the next three decades. To address historical stagnation and corporate retreat, the discussion emphasized a strategic pivot toward diverse biological hypotheses, early biomarker detection, and philanthropic de-risking led by organizations like the Gates Foundation. This approach aims to overcome diagnostic delays and therapeutic failures by integrating real-world data, stem cell modeling, and patient-centric outcomes to accelerate the development of rapid-acting treatments.